Lowenthal Richard E (CIK 1378550) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-08-22). Recent activity: Sell SPRY (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-22 | ARS Pharmaceuticals, Inc. (SPRY) | PRESIDENT AND CEO | Sell | 50,000 | $724,500 |
Source: SEC Form 4 filings · as of 2025-08-22